# Amyotrophic Lateral Sclerosis Patients Show Higher Urinary Levels of Lead and Copper: A Pilot Case-Control Study

**Authors:** Ana Santurtún, Lucía Pérez-Soberón, María José Sedano, Javier Riancho

PMC · DOI: 10.3390/biomedicines13102385 · Biomedicines · 2025-09-29

## TL;DR

This study found higher levels of lead and copper in the urine of ALS patients compared to healthy controls, suggesting possible environmental factors in the disease.

## Contribution

The study is the first to report elevated urinary lead and copper in ALS patients who have not changed their living environment.

## Key findings

- ALS patients had significantly higher urinary lead and copper levels compared to healthy controls.
- A subtle increase in manganese was also observed in ALS patients.
- Urine levels reflect recent exposure to heavy metals, possibly linked to the residential environment or dietary habits.

## Abstract

Background/Objectives: Amyotrophic Lateral Sclerosis (ALS) is the most frequent neurodegenerative disease affecting motor neurons. Sporadic ALS cases, which represent over 90% of the total, result from the interaction between genetic predisposition, aging, and environmental factors. Regarding natural environmental risk factors, the analysis of the role of exposure to heavy metals is of particular interest due to the well-known neurological effects of certain compounds. This study aims to compare the levels of heavy metals in urine samples in a cohort of patients with ALS who have not changed their living environment with the levels found in healthy controls (HCs). Methods: A cross-sectional case-control (14 patients with ALS vs. 28 HC) observational study was conducted in which urine samples were analyzed for five heavy metals (lead, manganese, selenium, copper, and zinc) using Inductively Coupled Plasma Mass Spectrometry (ICP-MS). Results: The patients with ALS showed significantly higher urine levels of lead (p < 0.001) and copper (p = 0.007) and a subtle increase in manganese concentrations (p = 0.043). Urine samples reflect recent exposures, so if the source of metals was related to the residential environment (the patients in the present study had not moved), dietary habits, or certain activities or hobbies that had not changed since diagnosis, it would be representative. Conclusions: In this pilot study, patients with ALS presented higher urinary levels of lead, manganese, and copper. Future larger studies are needed to elucidate the precise role of these heavy metals in ALS pathogenesis.

## Linked entities

- **Chemicals:** lead (PubChem CID 5352425), copper (PubChem CID 23978), manganese (PubChem CID 23930), selenium (PubChem CID 6326970), zinc (PubChem CID 23994)
- **Diseases:** Amyotrophic Lateral Sclerosis (MONDO:0004976)

## Full-text entities

- **Diseases:** ALS (MESH:D000690), Sporadic ALS (MESH:C531617), neurodegenerative disease (MESH:D019636)
- **Chemicals:** manganese (MESH:D008345), Lead (MESH:D007854), heavy metals (MESH:D019216), selenium (MESH:D012643), Copper (MESH:D003300), zinc (MESH:D015032)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12561292/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12561292/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12561292/full.md

---
Source: https://tomesphere.com/paper/PMC12561292